FOLVITE Trademark

Trademark Overview

On Thursday, August 28, 2014, a trademark application was filed for FOLVITE with the United States Patent and Trademark Office. The USPTO has given the FOLVITE trademark a serial number of 86379547. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 23, 2019. This trademark is owned by Amneal Pharmaceuticals LLC. The FOLVITE trademark is filed in the Pharmaceutical Products category with the following description:

Folic acid preparations, namely, pharmaceutical dosage forms and dietary supplements, both containing folic acid in powder, liquid, pill, capsule and caplet form; Dietary and pharmaceutical preparations containing folic acid for preventing and treating folate deficiency anemia, birth defects, miscarriage, memory loss Alzheimer's disease, and depression
folvite

General Information

Serial Number86379547
Word MarkFOLVITE
Filing DateThursday, August 28, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 23, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 28, 2016

Trademark Statements

Goods and ServicesFolic acid preparations, namely, pharmaceutical dosage forms and dietary supplements, both containing folic acid in powder, liquid, pill, capsule and caplet form; Dietary and pharmaceutical preparations containing folic acid for preventing and treating folate deficiency anemia, birth defects, miscarriage, memory loss Alzheimer's disease, and depression

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 10, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAmneal Pharmaceuticals LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressBridgewater, NJ 08807
Party NameAmneal Pharmaceuticals LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBridgewater, NJ 08807

Trademark Events

Event DateEvent Description
Monday, September 1, 2014NEW APPLICATION ENTERED
Wednesday, September 10, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 11, 2014ASSIGNED TO EXAMINER
Monday, December 15, 2014NON-FINAL ACTION WRITTEN
Monday, December 15, 2014NON-FINAL ACTION E-MAILED
Monday, December 15, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 14, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 14, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 15, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 19, 2015SUSPENSION LETTER WRITTEN
Monday, January 19, 2015LETTER OF SUSPENSION E-MAILED
Monday, January 19, 2015NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, July 20, 2015REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, February 1, 2016NON-FINAL ACTION WRITTEN
Monday, February 1, 2016NON-FINAL ACTION E-MAILED
Monday, February 1, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 17, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 17, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 17, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 9, 2016FINAL REFUSAL WRITTEN
Wednesday, March 9, 2016FINAL REFUSAL E-MAILED
Wednesday, March 9, 2016NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, May 25, 2016EXAMINERS AMENDMENT E-MAILED
Wednesday, May 25, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, May 25, 2016EXAMINERS AMENDMENT -WRITTEN
Wednesday, May 25, 2016EXAMINER'S AMENDMENT ENTERED
Wednesday, May 25, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 8, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 28, 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 28, 2016PUBLISHED FOR OPPOSITION
Tuesday, June 28, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 23, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, February 1, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 1, 2017SOU TEAS EXTENSION RECEIVED
Wednesday, February 1, 2017SOU EXTENSION 1 FILED
Wednesday, February 1, 2017SOU EXTENSION 1 GRANTED
Friday, February 3, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 11, 2017SOU TEAS EXTENSION RECEIVED
Friday, August 11, 2017SOU EXTENSION 2 FILED
Friday, August 11, 2017SOU EXTENSION 2 GRANTED
Tuesday, August 15, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 15, 2018SOU TEAS EXTENSION RECEIVED
Thursday, February 15, 2018SOU EXTENSION 3 FILED
Thursday, February 15, 2018SOU EXTENSION 3 GRANTED
Saturday, February 17, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 1, 2018SOU TEAS EXTENSION RECEIVED
Wednesday, August 1, 2018SOU EXTENSION 4 FILED
Wednesday, August 1, 2018SOU EXTENSION 4 GRANTED
Friday, August 3, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 21, 2019SOU TEAS EXTENSION RECEIVED
Monday, January 21, 2019SOU EXTENSION 5 FILED
Thursday, January 31, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, January 31, 2019SOU EXTENSION 5 GRANTED
Friday, February 1, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 23, 2019ABANDONMENT - NO USE STATEMENT FILED
Monday, September 23, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Wednesday, June 1, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, January 29, 2025ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

Related Keywords

folvite folic acid pharmaceutical containing dietary preparations birth deficiency folate defects